Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Ariad Pharm Inc (NASDAQ: ARIA)

$23.99 USD $0.04 (0.17%)
Last Price $23.99
Net Change $0.04 (0.17%)
Bid $
Ask Price $
Open Price $23.95
Previous Close Price $23.95
High Price $23.99
Low Price $23.94
Number of Trades 0
Volume 7,220,900
Fifty Two Week High $23.99 (2017-02-15)
Fifty Two Week Low $4.67 (2016-02-24)
Average Daily Volume 15,701,480
Share Outstanding 194,390 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.12 (2016-11-07)
2nd Quarter Earnings $0.59 (2016-07-28)
3nd Quarter Earnings $-0.23 (2016-05-10)
4th Quarter Earnings $-0.32 (2016-02-23)
PE Ratio $0
EPS Growth $-916.65
Recent Earnings $-0.12
Annual EPS $-0.17
Last Quarter EPS $
Market Capitalization $4.66B
Insider Shareholders % 0.082%
Annual Revenue $0B
No. Shares Outstanding 194,390
Inst. Shareholder % 86.97%
Annual Net Income $0B
TTM Net Profit Margin $101.23
1-Year Return 369.47%
3-Year Return 172.92%
5-Year Return 65.91%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -916.650024%
Dividends per Share $
Stock Split Ratio
Beta 2.16
Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.